-Bisphosphonates, commonly used to treat osteoporosis and bone-related conditions, have been investigated for their potential neuroprotective effects in PD. Some studies suggest that bisphosphonates may reduce neuroinflammation and protect against dopaminergic cell loss in PD models. Specific drugs considered for repurposing to treat PD are presented further in the paper, in the drug repurposing section.